Lehtonen Š - Search Results

1

Metabolic alterations in Parkinson's disease astrocytes.

Sonninen TM, Hämäläinen RH, Koskuvi M, Oksanen M, Shakirzyanova A, Wojciechowski S, Puttonen K, Naumenko N, Goldsteins G, Laham-Karam N, Lehtonen M, Tavi P, Koistinaho J, Lehtonen Š. Sonninen TM, et al. Among authors: lehtonen s, lehtonen m. Sci Rep. 2020 Sep 2;10(1):14474. doi: 10.1038/s41598-020-71329-8. Sci Rep. 2020. PMID: 32879386 Free PMC article.

2

A prolyl oligopeptidase inhibitor, Z-Pro-Prolinal, inhibits glyceraldehyde-3-phosphate dehydrogenase translocation and production of reactive oxygen species in CV1-P cells exposed to 6-hydroxydopamine.

Puttonen KA, Lehtonen S, Raasmaja A, Männistö PT. Puttonen KA, et al. Among authors: lehtonen s. Toxicol In Vitro. 2006 Dec;20(8):1446-54. doi: 10.1016/j.tiv.2006.07.001. Epub 2006 Jul 14. Toxicol In Vitro. 2006. PMID: 16942854

3

Different viabilities and toxicity types after 6-OHDA and Ara-C exposure evaluated by four assays in five cell lines.

Puttonen KA, Lehtonen S, Lampela P, Männistö PT, Raasmaja A. Puttonen KA, et al. Among authors: lehtonen s. Toxicol In Vitro. 2008 Feb;22(1):182-9. doi: 10.1016/j.tiv.2007.07.005. Epub 2007 Jul 26. Toxicol In Vitro. 2008. PMID: 17764891

4

Production of monocytic cells from bone marrow stem cells: therapeutic usage in Alzheimer's disease.

Magga J, Savchenko E, Malm T, Rolova T, Pollari E, Valonen P, Lehtonen Š, Jantunen E, Aarnio J, Lehenkari P, Koistinaho M, Muona A, Koistinaho J. Magga J, et al. Among authors: lehtonen s. J Cell Mol Med. 2012 May;16(5):1060-73. doi: 10.1111/j.1582-4934.2011.01390.x. J Cell Mol Med. 2012. PMID: 21777378 Free PMC article.

5

Nrf2 regulates neurogenesis and protects neural progenitor cells against Aβ toxicity.

Kärkkäinen V, Pomeshchik Y, Savchenko E, Dhungana H, Kurronen A, Lehtonen S, Naumenko N, Tavi P, Levonen AL, Yamamoto M, Malm T, Magga J, Kanninen KM, Koistinaho J. Kärkkäinen V, et al. Among authors: lehtonen s. Stem Cells. 2014 Jul;32(7):1904-16. doi: 10.1002/stem.1666. Stem Cells. 2014. PMID: 24753106

6

Interleukin-33 treatment reduces secondary injury and improves functional recovery after contusion spinal cord injury.

Pomeshchik Y, Kidin I, Korhonen P, Savchenko E, Jaronen M, Lehtonen S, Wojciechowski S, Kanninen K, Koistinaho J, Malm T. Pomeshchik Y, et al. Among authors: lehtonen s. Brain Behav Immun. 2015 Feb;44:68-81. doi: 10.1016/j.bbi.2014.08.002. Epub 2014 Aug 18. Brain Behav Immun. 2015. PMID: 25153903

7

Transplanted Human Induced Pluripotent Stem Cell-Derived Neural Progenitor Cells Do Not Promote Functional Recovery of Pharmacologically Immunosuppressed Mice With Contusion Spinal Cord Injury.

Pomeshchik Y, Puttonen KA, Kidin I, Ruponen M, Lehtonen S, Malm T, Åkesson E, Hovatta O, Koistinaho J. Pomeshchik Y, et al. Among authors: lehtonen s. Cell Transplant. 2015;24(9):1799-812. doi: 10.3727/096368914X684079. Epub 2014 Sep 8. Cell Transplant. 2015. PMID: 25203632 Free article.

8

Immunomodulation by interleukin-33 is protective in stroke through modulation of inflammation.

Korhonen P, Kanninen KM, Lehtonen Š, Lemarchant S, Puttonen KA, Oksanen M, Dhungana H, Loppi S, Pollari E, Wojciechowski S, Kidin I, García-Berrocoso T, Giralt D, Montaner J, Koistinaho J, Malm T. Korhonen P, et al. Among authors: lehtonen s. Brain Behav Immun. 2015 Oct;49:322-36. doi: 10.1016/j.bbi.2015.06.013. Epub 2015 Jun 22. Brain Behav Immun. 2015. PMID: 26111431

9

ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.

Lemarchant S, Pomeshchik Y, Kidin I, Kärkkäinen V, Valonen P, Lehtonen S, Goldsteins G, Malm T, Kanninen K, Koistinaho J. Lemarchant S, et al. Among authors: lehtonen s. Mol Neurodegener. 2016 Jan 25;11:10. doi: 10.1186/s13024-016-0078-3. Mol Neurodegener. 2016. PMID: 26809777 Free PMC article.

10

Erratum to: ADAMTS-4 promotes neurodegeneration in a mouse model of amyotrophic lateral sclerosis.

Lemarchant S, Pomeshchik Y, Kidin I, Kärkkäinen V, Valonen P, Lehtonen S, Goldsteins G, Malm T, Kanninen K, Koistinaho J. Lemarchant S, et al. Among authors: lehtonen s. Mol Neurodegener. 2016 Feb 8;11:15. doi: 10.1186/s13024-016-0080-9. Mol Neurodegener. 2016. PMID: 26858022 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

223 results

Search Page